LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ONCO Onconetix
- 0.385
- +0.035+10.00%
Close Dec 27 16:00 ET
- 0.392
- +0.007+1.79%
Post 19:58 ET
3.19MMarket Cap0.00P/E (TTM)
0.420High0.355Low3.05MVolume0.375Open0.350Pre Close1.19MTurnover87.30%Turnover Ratio0.00P/E (Static)8.29MShares21.40052wk High0.09P/B1.35MFloat Cap0.31652wk Low--Dividend TTM3.49MShs Float3636.000Historical High--Div YieldTTM18.51%Amplitude0.315Historical Low0.391Avg Price1Lot Size
About Onconetix Company
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Company Profile
SymbolONCO
Company NameOnconetix
Listing DateFeb 18, 2022
Founded2018
CEODr. Ralph Schiess
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address201 East 5th Street,Suite 1900
CityCincinnati
ProvinceOhio
CountryUnited States of America
Zip Code45202
Phone1-513-620-4101
Websitehttp://www.onconetix.com
Company Executives
- Name
- Position
- Salary
- Dr. Ralph Schiess
- Chief Science Officer and Interim Chief Executive Officer
- --
- Karina M. Fedasz
- Interim Chief Financial Officer
- --
- Christian Bruhlmann
- Chief Strategy Officer
- --
- James Sapirstein
- Non-Executive Chairman of the Board and Lead Independent Director
- 182.12K
- Dr. Ajit Singh, PhD.
- Director
- --
- Dr. Thomas Meier, PhD
- Director
- --
- Simon Tarsh
- Independent Director
- 112.62K
- Timothy R. Ramdeen
- Independent Director
- 82.67K
